Fig. 6From: The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic miceProlonged Dasatinib treatment does not alter the plasma levels of insulin or adipokines in db/db mice. Circulating levels of Insulin (A), Leptin (B), MCP1 (C), Resistin (D), PAI-1 (E), and IL-6 (F). Bar graphs show individual values and means ± SEM. n = 7 to 8 animals per groupBack to article page